The largest database of trusted experimental protocols
> Living Beings > Bacterium > Leptospira

Leptospira

Leptospira is a genus of spirochete bacteria that can cause the infectious disease leptospirosis.
These bacteria are found worldwide, particularly in tropical and subtropical regions, and can infect a variety of animals, including rodents, livestock, and humans.
Leptospirosis is a zoonotic disease, meaning it can be transmitted from animals to humans.
Symptoms can range from mild flu-like illness to severe, potentially fatal complications.
Proper diagnosis and treatment are important for managing leptospirosis.
Researchers studying Leptospira can utilize the PubCompare.ai platform to optimzie their research, locate the best protocols, and enhance reproducibility and accuracy of their studies, taking their Leptospira research to new heights.

Most cited protocols related to «Leptospira»

Bacterial strains (Table 1) were cultured by the WHO reference laboratory at the KIT Biomedical Research Centre at The Royal Tropical Institute, Amsterdam, The Netherlands (all isolates and reference strains labelled RK3) and at the Veterinary Sciences Division (VSD), The Queen's University of Belfast, United Kingdom (reference strains labelled RB3) and the WHO reference centre at Port Blair India (labelled isol 15). A total of 120 strains consisting of 79 isolates and 41 reference strains from different sources and geographical regions were analyzed by MLST. The 41 reference strains included in the study belonged to six Leptospira species (L. interrogans; L. kirschneri; L. noguchii; L. borgpetersenii; L. santarosai and L. alexanderi).
Full text: Click here
Publication 2006
Bacteria Leptospira Strains
Sequence types and the associated sequence data for the seven MLST loci were downloaded from the Leptospira MLST website (http://leptospira.mlst.net) for 199 isolates. MLST was performed using the original scheme for an additional 52 Leptospira isolates that had not been genotyped previously. These included 38 L. interrogans isolates from Laos (n = 11), Malaysia (n = 2), Sri Lanka (n = 14), Japan (n = 1) the Philippines (n = 2), or China (n = 8), and 14 L. kirschneri isolates from Japan (n = 2) or reference collections (n = 12). Alleles were assigned and sequence types defined using the MLST website. The 251 isolates typed by the original scheme are detailed in Table S1.
Full text: Click here
Publication 2013
Alleles Leptospira
The primers and probes were designed from alignments of available Leptospira spp. 16S rDNA partial sequences obtained from the GenBank nucleotide sequence database (data not shown). The program used was Primer Express™ (Perkin-Elmer, Applied Biosystems, USA). The ability of the primers and probe to identify leptospiral sequences was initially assessed using the BLAST program [20 (link)] against the National Center for Biotechnology Information (NCBI) sequence database. The primers were synthesized by Geneworks Pty. Ltd., Australia and the probe by Pacific Oligos Pty Ltd, Australia.
The PCR primers Lepto F (5'171 CCCGCGTCCGATTAG 3') and Lepto R (5'258 TCCATTGTGGCCGRA/GACAC3') were located between the positions 171 and 258 of the rrs (16S) gene with an expected product size of 87 bp product. The probe [5'205(FAM) CTCACCAAGGCGACGATCGGTAGC228 3' (TAMRA)] had the fluorescent reporter dye, 6-carboxy-fluorescein (FAM) located at the 5' end of the probe and the quencher 6-carboxy-tetramethyl-rhodamine (TAMRA) located at the 3' end.
Publication 2002
2',5'-oligoadenylate 6-carboxyfluorescein Base Sequence DNA, Ribosomal Fluorescent Dyes Genes Leptospira Nucleotides Oligonucleotide Primers tetramethylrhodamine
The prospective cohort study was conducted in the community of Pau da Lima (13°32’53.47” S; 38°43’51.10” W). This slum (favela) settlement (Fig 1) is situated in the periphery of Salvador (population, 2,892,625 inhabitants), Brazil [24 ]. The study site, which has been previously described,[21 (link)] has conditions of poverty, land use and climate that are similar to other slum settlements in Brazil and tropical regions in the developing world. In 2003, a study census identified 14,122 inhabitants residing in 3,689 households within the four-valley site with area 0.46 Km2. The majority (85%) of inhabitants were squatters who did not have legal title to their domiciles. Median household per capita income was US$1.30 per day. The mean annual incidence of hospitalized leptospirosis at the site was 57.8 cases per 100,000 population between 1996 and 2002 [21 (link)]. A one-year seroincidence study of 2,003 residents identified a Leptospira infection rate of 37.8 per 1,000 person-years at the study site [21 (link)].
A sample of 684 (18% of 3,689) households of all inhabited domiciles was selected using a computer-based random number generator. The sample size of this cohort was informed by seroprevalence surveys [12 (link)] and by case-control investigations [19 (link)], which found that the frequency of identified risk exposures for anti-Leptospira antibodies and leptospirosis is between 20–40% among community individuals. Based on these data, the study was powered to detect a risk ratio of at least 2.0 for potential risk exposures. All subjects aged five years or more who slept three or more nights per week in the sampled households were eligible for enrolment in the cohort study. Subjects were enrolled between February 2003 and May 2004, according to written informed consent procedures approved by the Institutional Review Boards of the Oswaldo Cruz Foundation and Brazilian National Commission for Ethics in Research, Brazilian Ministry of Health, Weill Medical College of Cornell University, and Yale University School of Public Health.
Full text: Click here
Publication 2016
Anti-Antibodies Brodmann Area 46 Climate Ethics Committees, Research Head Households Leptospira Leptospirosis PER1 protein, human Sleep Squatters
The 327 Leptospira spp. used in this study are listed in Table S1. Genomic DNA was extracted as described previously [20] (link), with the exception of isolates from the National Center for Emerging and Zoonotic Infectious Diseases, Centers for Diseases Control and Prevention, USA, which were extracted with the addition of dimethyl sulfoxide. For isolates for which the species was unknown, identification was undertaken by amplification and sequencing of the near full-length 16S rRNA gene (rrs), as described previously [20] (link). Sequence data for rrs has been deposited in GenBank (see Table S2 for accession numbers). The serovars of isolates from recent human leptospirosis cases in Thailand, Laos and Sri Lanka were determined by the WHO/FAO/OIE Collaborating Center for Reference and Research on Leptospirosis, Queensland Health Forensic and Scientific Services, Brisbane, Australia using the cross-agglutinin absorption test (CAAT). The serovars of contemporary isolates from China were determined using CAAT at the China Medical Culture Collection of National Institutes for Food and Drug Control, China.
Ethical approvals to obtain contemporary clinical isolates of Leptospira spp. are as follows. Isolates from patients in northeast Thailand between October 2000 and December 2006 were obtained during a prospective study of acute febrile illness [20] (link), which was approved by the Ethical Committee of the Ministry of Public Health, Royal Government of Thailand. Isolates from patients in Laos between August 2006 and October 2009 were obtained during a prospective fever study approved by the Oxford Tropical Research Ethics Committee (OXTREC) and the National Ethics Committee for Health Research (NECHR), Ministry of Health, Government of Lao PDR. Isolates obtained from patients in Sri Lanka between June 2006 and May 2007 were obtained during a prospective fever study approved by the Research Ethics Committee of the Liverpool School of Tropical Medicine, UK and the Ethical Review Committee of the Faculty of Medicine of the University of Kelaniya, Sri Lanka. Written informed consent was obtained from all subjects except where not required (not required for data analyzed anonymously in Laos PDR at the time of the study). Other clinical isolates were obtained from the China Medical Culture Collection of National Institutes for Food and Drug Control, China, and the National Center for Emerging and Zoonotic Infectious Diseases, Centers for Diseases Control and Prevention, USA. All data were analyzed anonymously.
Full text: Click here
Publication 2013
Agglutinins Ethics Committees, Research Faculty, Medical Fever Food Genome Homo sapiens Leptospira Leptospirosis Patients Ribosomal RNA Genes Sulfoxide, Dimethyl Zoonoses

Most recents protocols related to «Leptospira»

The Microagglutination Test (MAT), the reference serological test, was used for processing samples, considering a titer of ≥1:200 as a criterion of positivity. This is the cut-off point used in cattle in Argentina since leptospirosis is an endemic disease and because cattle are vaccinated in areas where this agent is present (17 ). Antibodies against pathogenic Leptospira were detected by the MAT in the Leptospirosis Laboratory, Department of Rural Zoonosis (Ministry of Health of Buenos Aires Province), according to WOAH (18 ) protocols.
A panel of live antigens of ten Leptospira spp. reference strains were used: L. interrogans serogroup Canicola serovar Canicola strain H. Utrecht IV, serogroup Hebdomadis serovar Hebdomadis strain Hebdomadis, serogroup Icterohaemorrhagiae serovar Copenhageni strain M20, serogroup Pomona serovar Pomona strain Pomona, serogroup Pyrogenes serovar Pyrogenes strain Salinem, serogroup Sejroe serovar Wolfii strain 3,705 and serogroup Sejroe serovar Hardjo strain Hardjoprajitno, L. borgpeterseni serogroup Ballum serovar Castellonis strain Castellon 3 and serogroup Tarassovi serovar Tarassovi strain Perepelitsin and L. kirschneri serogroup Grippotyphosa serovar Grippotyphosa strain Castellon 3. This panel was developed at 28–30°C in the Ellinghausen-McCullough-Johnson-Harris (EMJH) medium with no more than 15 days of growth. Serial serum dilutions were performed with phosphate-buffered saline (PBS, pH 7.2) starting from 1:100 dilution. The plates were incubated at 37°C for 90 min. After incubation, the serum-antigen mixtures were checked for agglutination under a dark field microscope. Tests were interpreted as positive when agglutination at ≥ 1:200 of at least 50% of the leptospires for any serogroup was observed. The highest serum dilution with >50% agglutination or ≤50% free leptospires, compared to the negative control, was considered the endpoint titer of quantitative MAT.
Full text: Click here
Publication 2023
Agglutination Antibodies Antigens Cattle Endemic Diseases Leptospira Leptospirosis Microscopy Pathogenicity Phosphates Saline Solution Serum Strains Technique, Dilution Tests, Serologic Zoonoses
The data about each animal, the characteristics of each farm and laboratory results were entered into an Excel database (Microsoft, Redmond, WA, USA). Prevalence of anti-Leptospira spp. antibodies with the 95% Confidence Interval (CI) was estimated. Also, farms positivity was determined. The association between the outcome seropositivity to Leptospira spp., to Leptospira serogroup Sejroe (adapted serogroup) and to Leptospira serogroup Pomona (incidental serogroup) and the variables under analysis was assessed by a bivariate analysis using a Chi-squared test. Fisher's exact test was used if one or more cells expected value was <5. Odds ratios (OR) and 95% CI were also estimated and calculated for each variable. For quantitative variables, parametric or non-parametric tests were used. The null hypothesis was that there were no differences between groups. All the statistical tests were carried out at α=0.05. Quantitative and qualitative variables at p-value < 0.2 in the bivariate analysis were analyzed by a Generalized Linear Mixed Model (GLMM) with random effect of farm-level risk. All statistical analyses were performed with software R v. 4.0.2 (10 ).
Potential spatial clusters were investigated in the study area with space scan statistics using SaTScan software, v10.0.2. Poisson model for high rates was performed for detecting spatial patterns of the number of MAT positive events in a geographical location, taking each farm as a unit for analysis according to a known population at risk (19 (link)).
Another qualitative variable called “being inside the spatial clusters” was generated, and an animal was considered to be exposed to the variable when it belonged to a farm inside a significant cluster. The animal was not exposed to the variable when it belonged to a farm outside the significant clusters. GLMM was performed with the significant variables detected in the first GLMM with a new variable, “being inside the spatial clusters.”
Full text: Click here
Publication 2023
Animals Anti-Antibodies Cells Leptospira Leptospira interrogans serovar pomona Radionuclide Imaging
A cross-sectional serological survey was carried on from September 2017 to December 2020. Using a probabilistic two-stage sampling, 25 farms and fifteen animals per farm were selected. SENASA (Servicio Nacional de Sanidad y Calidad Agroalimentaria) and Fundación Aftosa provided the region's database. In the first stage, the number of farms to be selected was calculated using the ProMesa 1.3 programme (12 ) using the following formula:
Where p is the expected seroprevalence of cows reactive to Leptospira, z is the confidence level, ROH is the homogeneity rate, b is the number of animals selected per farm and e is the acceptable (allowable) absolute error. Our assumptions were as follows: a prevalence of 20.33% (13 ), a relative error of 33%, a low homogeneity rate (0.06–0.12) (14 (link)) and 15 animals sampled per farm. The minimum sample size estimated was 25 farms (375 animals). More farms were included from Ayacucho (14) because this department has the largest number of cattle farms. The second stage was conducted on each farm through systematic randomization of the animals. The animals included in the study were bulls and breeding females ≥15 months of age, that were not vaccinated against Leptospira spp. or had been vaccinated more than 6 months before sampling. In addition, a questionnaire was administered to collect epidemiological information about the potential risk factors associated with seropositivity to Leptospira spp. The survey was based on general production and environmental characteristics, feeding practices, health and reproduction status. All farms were georeferenced using Global Positioning Systems (GPS) to perform spatial analysis and subsequent search for meteorological and satellite information such as the presence of water bodies, potential evapotranspiration, temperature and solar radiation. Water bodies were detected using information from the Landsat 8 satellite (spatial resolution of 30 meters) and calculated with MNDWI (Modified Normalized Difference Water Index) (15 (link)) with the QGIS software. The potential evapotranspiration was obtained through the EOS-Terra satellite and estimated using the ENVI software. The temperature was calculated monthly through data from the National Meteorological Service and solar radiation, using information from the sensor CERES (Clouds and the Earth's Radiant Energy System) (16 (link)). On the farms, blood samples were collected from the animals by venipuncture. The blood was allowed to clot at room temperature and centrifuged at 1,500 rpm for 15 min. The sera were separated and stored at −20°C.
Full text: Click here
Publication 2023
Animals BLOOD Cattle CERE Clotrimazole Farm Animals Females Leptospira Reproduction Serum Solar Energy Venipuncture Water, Body

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2023
Alamar Blue Biological Assay Cells Cell Survival Leptospira Metabolism Microbicides Plankton Technique, Dilution
Samples found to be positive for Leptospira via RT-PCR were then subject to conventional PCR (cPCR) targeting the 16S rDNA gene, using specific primers described elsewhere [50 (link)]. We used a HotStarTaq DNA Polymerase Kit (Qiagen, Courtaboeuf, France) and the following cPCR conditions: 15 min at 95 °C as the first denaturation step; 40 cycles of (a) 15 s at 95 °C for the second denaturation step, (b) 30 s at 57 °C as the annealing step, and (c) 1 min at 72 °C as the initial elongation step; and 10 min at 72 °C as the final elongation step. Each run included a negative control (the PCR mix without the target DNA) and a positive control (DNA from the L. interrogans serovar Icterohaemorrhagiae ENVN strain). The amplified products were verified utilizing electrophoresis on 1% agarose gel (30 min at 100 v). Under ultraviolet light (UV) conditions, the products’ molecular weights were assessed via comparisons with a 100-bp ladder (Invitrogen) and the positive control. The products were then subject to Sanger sequencing (performed by Genoscreen, Lille, France). ChromasPro (v. 2.6.6) was used to assemble the sequences, creating contigs. We then identified the Leptospira species present using an NCBI Nucleotide BLAST search (http://blast.ncbi.nlm.nih.gov, (accessed on 1 November 2022)).
Full text: Click here
Publication 2023
DNA, Ribosomal DNA-Directed DNA Polymerase Electrophoresis, Agar Gel Genes Leptospira Nucleotides Oligonucleotide Primers Reverse Transcriptase Polymerase Chain Reaction Strains

Top products related to «Leptospira»

Sourced in Germany, United States, France, United Kingdom, Netherlands, Spain, Japan, China, Italy, Canada, Switzerland, Australia, Sweden, India, Belgium, Brazil, Denmark
The QIAamp DNA Mini Kit is a laboratory equipment product designed for the purification of genomic DNA from a variety of sample types. It utilizes a silica-membrane-based technology to efficiently capture and purify DNA, which can then be used for various downstream applications.
Sourced in Germany, United States, United Kingdom, Spain, Canada, Netherlands, Japan, China, France, Australia, Denmark, Switzerland, Italy, Sweden, Belgium, Austria, Hungary
The DNeasy Blood and Tissue Kit is a DNA extraction and purification product designed for the isolation of genomic DNA from a variety of sample types, including blood, tissues, and cultured cells. The kit utilizes a silica-based membrane technology to efficiently capture and purify DNA, providing high-quality samples suitable for use in various downstream applications.
Sourced in United States, France, Germany, China, United Kingdom, Japan, Switzerland, Australia, Spain, Italy, Ireland, Canada, Brazil
The Wizard Genomic DNA Purification Kit is a product designed to isolate and purify genomic DNA from a variety of sample types. It utilizes a simple, rapid, and efficient protocol to extract high-quality DNA that can be used in various downstream applications.
Sourced in Germany, United States, Spain, United Kingdom, Japan, Netherlands, France, China, Canada, Italy, Australia, Switzerland, India, Brazil, Norway
The QIAamp DNA Blood Mini Kit is a laboratory equipment designed for the extraction and purification of genomic DNA from small volumes of whole blood, buffy coat, plasma, or serum samples. It utilizes a silica-based membrane technology to efficiently capture and wash DNA, while removing contaminants and inhibitors.
Sourced in United States, United Kingdom, Germany, China, Canada, Italy, Japan, Switzerland, Australia, Lithuania, Spain, France, Denmark, Ireland, Israel, Singapore, Belgium, India, Portugal, Hong Kong
SYBR Green PCR Master Mix is a ready-to-use solution for real-time PCR amplification and detection. It contains SYBR Green I dye, DNA polymerase, dNTPs, and necessary reagents for efficient DNA amplification and fluorescent detection.
Sourced in United States, United Kingdom, Germany, Brazil, Belgium, Ireland, Japan, Spain, China, Canada
The PureLink Genomic DNA Mini Kit is a DNA extraction and purification kit designed to isolate high-quality genomic DNA from a variety of sample types. It utilizes a silica-based membrane technology to efficiently capture and purify DNA, while removing contaminants and inhibitors.
Sourced in United States
Epi Info version 7 is a free, public domain software package designed for the Microsoft Windows operating system. It is developed by the Centers for Disease Control and Prevention (CDC) for the purpose of data entry, data management, and epidemiological analysis.
Sourced in Germany, Denmark, United States, New Zealand
CLC Genomics Workbench 9.5 is a software application for analyzing and visualizing genomic data. It provides tools for tasks such as sequence alignment, assembly, variant calling, and functional annotation. The software supports a wide range of file formats and data types, making it a versatile tool for bioinformatics analysis.
Sourced in United States, France
The NextSeq 500 Sequencing System is a high-throughput, next-generation sequencing (NGS) platform designed for a wide range of applications, including whole-genome sequencing, exome sequencing, targeted gene panels, and gene expression analysis. The system utilizes Illumina's proprietary sequencing-by-synthesis (SBS) chemistry to generate high-quality sequencing data.
Sourced in United States, United Kingdom, Germany, France, Canada, Italy, Brazil, Japan
The Nextera XT DNA Library Preparation Kit is a lab equipment product designed for efficient and rapid construction of DNA libraries for next-generation sequencing. The kit provides a streamlined workflow for preparing DNA samples for sequencing on Illumina platforms.

More about "Leptospira"

Leptospira is a genus of spiral-shaped, motile bacteria that can cause the serious infectious disease known as leptospirosis.
These gram-negative spirochetes are found worldwide, especially in tropical and subtropical regions, and can infect a wide range of animal hosts, including rodents, livestock, and humans.
Leptospirosis is a zoonotic disease, meaning it can be transmitted from animals to people.
The symptoms of leptospirosis can vary greatly, ranging from a mild, flu-like illness to severe, potentially fatal complications such as organ failure and internal bleeding.
Proper and timely diagnosis and treatment are crucial for managing leptospirosis effectively.
Researchers studying Leptospira can utilize advanced tools and techniques to optimize their research, locate the best protocols, and enhance the reproducibility and accuracy of their studies.
One such tool is the PubCompare.ai platform, which leverages artificial intelligence to help researchers identify the most effective methods and protocols from the scientific literature, preprints, and patents.
By utilizing PubCompare.ai, researchers can ensure they are using the most up-to-date and reliable techniques, such as those from the QIAamp DNA Mini Kit, DNeasy Blood and Tissue Kit, Wizard Genomic DNA Purification Kit, QIAamp DNA Blood Mini Kit, SYBR Green PCR Master Mix, and PureLink Genomic DNA Mini Kit.
Additionally, researchers can take advantage of data analysis software like Epi Info version 7 and CLC Genomics Workbench 9.5, as well as high-throughput sequencing platforms like the NextSeq 500 Sequencing System and Nextera XT DNA Library Preparation Kit, to enhance the quality and depth of their Leptospira research.
By incorporating these tools and techniques, researchers can truly take their Leptospira studies to new heights, advancing our understanding of this important and complex genus of bacteria.